Amphastar Pharmaceuticals, Inc. (AMPH)
NASDAQ: AMPH · IEX Real-Time Price · USD
33.25
-1.03 (-3.00%)
Jun 28, 2022 4:00 PM EDT - Market closed
Income Statement (Annual)
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue
|
437.77 | 349.85 | 322.36 | 294.67 | 240.18 | 255.17 | 251.52 | 210.46 | 229.68 | 204.32 | Upgrade
|
Revenue Growth (YoY)
|
25.13% | 8.53% | 9.40% | 22.69% | -5.88% | 1.45% | 19.51% | -8.37% | 12.41% | 72.63% | Upgrade
|
Cost of Revenue
|
238.03 | 206.51 | 190.43 | 187.68 | 149.67 | 150.97 | 174.17 | 159.21 | 142.73 | 114.02 | Upgrade
|
Gross Profit
|
199.74 | 143.34 | 131.92 | 106.99 | 90.51 | 104.2 | 77.35 | 51.26 | 86.96 | 90.3 | Upgrade
|
Selling, General & Admin
|
68.92 | 65.16 | 63.11 | 58.04 | 50.92 | 47.3 | 46.97 | 40.37 | 36.32 | 31.65 | Upgrade
|
Research & Development
|
60.93 | 67.23 | 68.85 | 57.56 | 43.5 | 41.52 | 37.27 | 28.87 | 33.02 | 31.16 | Upgrade
|
Other Operating Expenses
|
0 | 0 | 0 | 0 | -2.64 | 0 | 0 | 0 | 0.13 | 2.09 | Upgrade
|
Operating Expenses
|
129.85 | 132.39 | 131.96 | 115.61 | 91.78 | 88.82 | 84.25 | 69.24 | 69.47 | 64.91 | Upgrade
|
Operating Income
|
69.89 | 10.95 | -0.04 | -8.62 | -1.27 | 15.38 | -6.9 | -17.98 | 17.49 | 25.4 | Upgrade
|
Interest Expense / Income
|
0.89 | 0.37 | 0.12 | 0.24 | 0.83 | 1.02 | 0.99 | 0.61 | 0.96 | 0.78 | Upgrade
|
Other Expense / Income
|
-13.74 | 5.64 | -62.82 | 0.14 | -3.34 | -0.28 | 2.48 | -0.44 | -0.7 | -1.27 | Upgrade
|
Pretax Income
|
82.75 | 4.94 | 62.66 | -9 | 1.25 | 14.63 | -10.36 | -18.15 | 17.23 | 25.88 | Upgrade
|
Income Tax
|
20.63 | 3.54 | 13.72 | -3.27 | -2.4 | 4.81 | -7.58 | -7.45 | 5.37 | 7.78 | Upgrade
|
Net Income
|
62.12 | 1.4 | 48.94 | -5.74 | 3.65 | 9.82 | -2.79 | -10.7 | 11.86 | 18.09 | Upgrade
|
Net Income Common
|
62.12 | 1.4 | 48.94 | -5.74 | 3.65 | 9.82 | -2.79 | -10.7 | 11.86 | 18.09 | Upgrade
|
Net Income Growth
|
4327.37% | -97.13% | - | - | -62.86% | - | - | - | -34.44% | 133.41% | Upgrade
|
Shares Outstanding (Basic)
|
48 | 47 | 47 | 46 | 46 | 45 | 45 | 42 | 39 | 39 | Upgrade
|
Shares Outstanding (Diluted)
|
50 | 49 | 50 | 46 | 48 | 48 | 45 | 42 | 39 | 39 | Upgrade
|
Shares Change
|
1.34% | -1.57% | 7.57% | -4.08% | 1.82% | 5.66% | 7.16% | 7.91% | -0.15% | 0.05% | Upgrade
|
EPS (Basic)
|
1.30 | 0.03 | 1.04 | -0.12 | 0.08 | 0.22 | -0.06 | -0.25 | 0.31 | 0.47 | Upgrade
|
EPS (Diluted)
|
1.25 | 0.03 | 0.98 | -0.12 | 0.08 | 0.21 | -0.06 | -0.25 | 0.31 | 0.46 | Upgrade
|
EPS Growth
|
4066.67% | -96.94% | - | - | -61.91% | - | - | - | -32.61% | 130.00% | Upgrade
|
Free Cash Flow Per Share
|
1.48 | 0.50 | 0.00 | -0.18 | 0.09 | 0.38 | -0.12 | 0.01 | 0.33 | -0.66 | Upgrade
|
Gross Margin
|
45.63% | 40.97% | 40.92% | 36.31% | 37.69% | 40.84% | 30.75% | 24.35% | 37.86% | 44.20% | Upgrade
|
Operating Margin
|
15.96% | 3.13% | -0.01% | -2.93% | -0.53% | 6.03% | -2.74% | -8.54% | 7.61% | 12.43% | Upgrade
|
Profit Margin
|
14.19% | 0.40% | 15.18% | -1.95% | 1.52% | 3.85% | -1.11% | -5.08% | 5.17% | 8.86% | Upgrade
|
Free Cash Flow Margin
|
16.11% | 6.69% | 0.06% | -2.84% | 1.71% | 6.73% | -2.11% | 0.26% | 5.55% | -12.39% | Upgrade
|
Effective Tax Rate
|
24.93% | 71.62% | 21.90% | 36.27% | -191.99% | 32.88% | 73.11% | 41.05% | 31.14% | 30.08% | Upgrade
|
EBITDA
|
109.09 | 29.46 | 82.87 | 5.77 | 15.03 | 27.82 | 1.94 | -5.01 | 29.36 | 36.32 | Upgrade
|
EBITDA Margin
|
24.92% | 8.42% | 25.71% | 1.96% | 6.26% | 10.90% | 0.77% | -2.38% | 12.78% | 17.77% | Upgrade
|
Depreciation & Amortization
|
25.46 | 24.14 | 20.08 | 14.53 | 12.95 | 12.16 | 11.31 | 12.53 | 11.17 | 9.66 | Upgrade
|
EBIT
|
83.63 | 5.32 | 62.78 | -8.76 | 2.08 | 15.65 | -9.38 | -17.54 | 18.19 | 26.66 | Upgrade
|
EBIT Margin
|
19.10% | 1.52% | 19.48% | -2.97% | 0.86% | 6.13% | -3.73% | -8.33% | 7.92% | 13.05% | Upgrade
|
Source: Financials are provided by
Nasdaq Data Link
and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).